One‐Year Clinical Course of Patients With Amyotrophic Lateral Sclerosis Admitted to a Home Palliative Care Program: An Extension Study
Muscle & Nerve · 2026-12 · 74 (6) · 1604-1610
DOI: 10.1002/mus.70429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 06.10.2026. Verfasst von Sebastiano Mercadante und 2 weiteren Autor:innen. Beteiligte Einrichtung: Main Regional Center of Pain Relief and Supportive/Palliative Care, La Maddalena Cancer Center, Palermo, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Palliative Care, Home Care Services. Die Arbeit nennt 25 Literaturangaben.
Themen: Palliativpflege
Abstract (Originalsprache)
Introduction/Aims Longer term data on ALS patients receiving home palliative care are scarce. We extended follow‐up of a 6‐month cohort to 12 months to characterize the trajectory of function, symptoms, vital support (noninvasive ventilation [NIV], gastrostomy, and/or tracheostomy), and advance care planning (ACP).
Methods
In this prospective, single‐center study, 34 consecutive ALS patients in a home palliative care program (SAMOT, Palermo) were assessed at baseline, 2, 4, 6, and 12 months, using Karnofsky, ALS Functional Rating Scale‐Revised (ALSFRS‐R), Edinburgh Cognitive and Behavioural ALS Screen (ECAS), Edmonton Symptom Assessment Scale (ESAS), dysphagia, vital support, and advanced care planning (ACP).
Results
Ten patients (29.4%) died over 12 months (70% at home); 26 completed the 12‐month assessment. Karnofsky (34.4–27.7) and ALSFRS‐R (27.1–21.7) declined significantly throughout (both p < 0.0005). Total ESAS rose from 15.7 to 23.7 ( p < 0.0005); anxiety increased significantly between T4 and T12. NIV use rose from 20.6% to 50.0% ( p = 0.014), while tracheostomy remained stable. Documented end‐of‐life decisions rose to 70.4% at 6 months but plateaued (69.2% at 12 months); no living wills were completed. Cognitive impairment on ECAS was present in about half of patients, unchanged over time. No patient was referred to or admitted to hospice.
Discussion
Extending follow‐up beyond 6 months shows continuous functional decline and rising symptom burden, and highlights late‐onset anxiety and early‐plateauing ACP. Despite progressive needs, this home palliative care model appeared to support most patients at home until death over 1 year, within this single‐center, non‐comparative cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Main Regional Center of Pain Relief and Supportive/Palliative Care, La Maddalena Cancer Center, Palermo, Italy.
- Regional Home Care Program, SAMOT, Palermo, Italy.
ORCID-Profile: Sebastiano Mercadante
Zitieren
APA
Mercadante, S., Petronaci, A., & Neuro Palliative Care Team of SAMOT (2026). One‐Year Clinical Course of Patients With Amyotrophic Lateral Sclerosis Admitted to a Home Palliative Care Program: An Extension Study. Muscle & Nerve, 74(6), 1604-1610. https://doi.org/10.1002/mus.70429
Vancouver
Mercadante S, Petronaci A, Neuro Palliative Care Team of SAMOT. One‐Year Clinical Course of Patients With Amyotrophic Lateral Sclerosis Admitted to a Home Palliative Care Program: An Extension Study. Muscle & Nerve. 2026;74(6):1604-1610. doi:10.1002/mus.70429
BibTeX
@article{Mercadante2026,
author = {Mercadante, Sebastiano and Petronaci, Antonino and Neuro Palliative Care Team of SAMOT, Neuro Palliative Care Team of SAMOT},
title = {One‐Year Clinical Course of Patients With Amyotrophic Lateral Sclerosis Admitted to a Home Palliative Care Program: An Extension Study},
journal = {Muscle & Nerve},
year = {2026},
volume = {74},
number = {6},
pages = {1604--1610},
doi = {10.1002/mus.70429}
}
EUVIMED